4//SEC Filing
Kamal Mostafa 4
Accession 0001209191-21-018374
CIK 0000019411other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:50 PM ET
Size
11.8 KB
Accession
0001209191-21-018374
Insider Transaction Report
Form 4
Kamal Mostafa
CEO, Magellan Rx Management
Transactions
- Exercise/Conversion
Ordinary Common Stock, $0.01 par value
2021-03-04+6,242→ 9,066 total - Tax Payment
Ordinary Common Stock, $0.01 par value
2021-03-04$93.47/sh−3,072$287,140→ 5,994 total - Award
Restricted Stock Units
2021-03-03+25,439→ 25,439 totalExercise: $0.00→ Common Stock (25,439 underlying) - Exercise/Conversion
Restricted Stock Units
2021-03-04−6,242→ 12,482 totalExercise: $0.00→ Common Stock (6,242 underlying)
Footnotes (6)
- [F1]This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on March 4, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
- [F2]Not applicable.
- [F3]Represents the portion of shares withheld by the Company in order to pay taxes.
- [F4]Closing price on NASDAQ on March 4, 2021.
- [F5]Restricted Stock Units vest in one third increments on March 3rd of each of 2022, 2023 and 2024, subject to earlier acceleration or forfeiture.
- [F6]The remainder of 12,482 Restricted Stock Units shall vest in equal increments on March 4, 2022 and 2023, subject to earlier acceleration or forfeiture.
Documents
Issuer
MAGELLAN HEALTH INC
CIK 0000019411
Entity typeother
Related Parties
1- filerCIK 0001647234
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:50 PM ET
- Size
- 11.8 KB